Synthetic Quantitative Array Technology Identifies the Ubp3-Bre5 Deubiquitinase Complex as a Negative Regulator of Mitophagy  by Müller, Matthias et al.
ResourceSynthetic Quantitative Array Technology Identifies
the Ubp3-Bre5 Deubiquitinase Complex as a
Negative Regulator of MitophagyGraphical AbstractHighlightsd Development of an enzyme-based high-throughput
screening technique in S. cerevisiae
d Genome-wide quantitative screen for modulators of
rapamycin-induced mitophagy
d Identification of 86 positive and 10 negative regulators of
mitophagy
d Reciprocal regulation of mitophagy and other autophagy
pathways by deubiquitinationMu¨ller et al., 2015, Cell Reports 10, 1215–1225
February 24, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.01.044Authors
Matthias Mu¨ller, Peter Ko¨tter, ...,
Karl-Dieter Entian, Andreas S. Reichert
Correspondence
reichert@hhu.de
In Brief
Mu¨ller et al. developed a method, termed
synthetic quantitative array technology,
to screen for mitophagy modulators in
yeast. Using this method, they identified
the Ubp3-Bre5 deubiquitination complex,
which inhibits mitophagy but promotes
other types of autophagy.
Deubiquitination thus appears to regulate
a switch between distinct autophagy
pathways.
Cell Reports
ResourceSynthetic Quantitative Array Technology Identifies
the Ubp3-Bre5 Deubiquitinase Complex
as a Negative Regulator of Mitophagy
Matthias Mu¨ller,1 Peter Ko¨tter,2 Christina Behrendt,1,3 Elena Walter,1 Christian Q. Scheckhuber,1,4 Karl-Dieter Entian,2
and Andreas S. Reichert1,3,*
1Mitochondrial Biology, Buchmann Institute for Molecular Life Sciences and Zentrum fu¨r Molekulare Medizin, Goethe University,
Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany
2Institut fu¨r Molekulare Biowissenschaften, Goethe University, Max-von-Laue-Straße 9, 60438 Frankfurt am Main, Germany
3Institute of Biochemistry and Molecular Biology I, Medical Faculty, Heinrich Heine University, Universita¨tsstraße 1, 40225 Du¨sseldorf,
Germany
4Present address: Integrative Fungal Research Cluster, Georg-Voigt-Straße 14-16, 60325 Frankfurt am Main, Germany
*Correspondence: reichert@hhu.de
http://dx.doi.org/10.1016/j.celrep.2015.01.044
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARY
Mitophagy is crucial to ensuringmitochondrial quality
control. However, the molecular mechanism and
regulation of mitophagy are still not fully understood.
Here, we developed a quantitative methodology
termed synthetic quantitative array (SQA) technol-
ogy, which allowed us to perform a genome-wide
screen formodulators of rapamycin-inducedmitoph-
agy in S. cerevisiae. SQA technology can be easily
employed for other enzyme-based reporter systems
and widely applied in yeast research. We identified
86 positive and 10 negative regulators of mitophagy.
Moreover, SQA-based analysis of non-selective
autophagy revealed that 63 of these regulators are
specific for mitophagy and 33 regulate autophagy in
general. The Ubp3-Bre5 deubiquitination complex
was found to inhibit mitophagy but, conversely,
to promote other types of autophagy, including
ribophagy. This complex translocates dynamically
to mitochondria upon induction of mitophagy. These
findings point to a role of ubiquitination in mitophagy
in yeast and suggest a reciprocal regulation of
distinct autophagy pathways.
INTRODUCTION
Mitochondria are double-membrane enclosed organelles that
serve central cellular functions such as production of ATP via
oxidative phosphorylation, iron-sulfur cluster biogenesis, and
regulation of apoptosis. They are the main source of reactive ox-
ygenspecies (ROS),whichpotentially cancause severeoxidative
damage to proteins, lipids, and DNA. Mitochondrial dysfunction
has been associated with aging and an increasing number of
diseases in humans, such as neurodegeneration, diabetes, and
cancer (Wallace, 2005).One important pathway formitochondrialCell Rquality control is the selective removal of mitochondria by an
autophagy-related process termed mitophagy (Lemasters,
2005). However, the detailedmolecularmechanismand in partic-
ular the regulation of this process are still not well understood.
Autophagy is a ubiquitous catabolic process that is highly
conserved among eukaryotes (Klionsky, 2007; Todde et al.,
2009). This ‘‘self-eating’’ process enables cells to adapt to
changes in nutrient availability and a variety of stress conditions.
Autophagy has long been assumed to be a non-selective pro-
cess that randomly degrades bulk portions of the cytoplasm,
but considerable progress has beenmade in identifying a variety
of selective types of autophagy (Suzuki, 2013). One well-known
example of this is the cytoplasm-to-vacuole targeting (Cvt)
pathway in yeast, which allows the selective delivery of at least
two resident hydrolases, aminopeptidase 1 (Ape1) and a-man-
nosidase 1 (Ams1), into the vacuole (Lynch-Day and Klionsky,
2010). Furthermore, the selective degradation of whole organ-
elles (e.g., mitochondria [mitophagy], peroxisomes [pexophagy],
ribosomes [ribophagy], and ER [ER-phagy]) and the removal of
aggregated proteins (aggrephagy) and invading bacteria (xen-
ophagy) have been investigated (Kraft et al., 2008; Lemasters,
2005; Suzuki, 2013; Youle and Narendra, 2011). Studies in yeast
and other fungi have revealed the identity of more than 30 auto-
phagy-related (ATG) genes so far (Klionsky, 2007). Many of these
genes are required for both non-selective and selective auto-
phagy, and thus form the core machinery for autophagy induc-
tion and autophagosome biogenesis. However, some ATG fac-
tors are only needed for distinct, selective types of autophagy.
In particular, the identification of Atg32 as a specific receptor
protein led todetailed informationabout the selective natureofmi-
tophagy (Kanki et al., 2009b; Okamoto et al., 2009). Atg32 is local-
ized to the mitochondrial outer membrane and interacts with
Atg11, a common adaptor protein for several selective types of
autophagy, upon induction of mitophagy, leading to recruitment
of mitochondria to the autophagymachinery. Atg32 was reported
to interact with Atg8, a ubiquitin (Ub)-like component of the auto-
phagosome, through theconservedconsensus sequenceW/YXX
I/L/V (Kondo-Okamoto et al., 2012). This sequence is called theeports 10, 1215–1225, February 24, 2015 ª2015 The Authors 1215
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Figure 1. SQA Technology
(A) Flow chart of the SQA technology applied to a genome-wide screen for
modulators of rapamycin-induced mitophagy.
(B) Outline of the modified SGA procedure for generating a yeast mutant
mitophagy tester library.
(C) Schematic overview of the high-throughput screening procedure for
analysis of rapamycin-induced mitophagy conducted in 96-well plates.Atg8 family interactingmotif (AIM) in yeast and the LC3 interacting
region (LIR) in mammalian cells, and is found ubiquitously in
various autophagy-receptor proteins (Noda et al., 2008).1216 Cell Reports 10, 1215–1225, February 24, 2015 ª2015 The AuthMitophagy has been analyzed in yeast cells after application of
the target of rapamycin (TOR) kinase inhibitor rapamycin (Kis-
sova´ et al., 2004; Mendl et al., 2011), upon nitrogen starvation
(Kanki and Klionsky, 2008), via post-log phase growth (Kanki
et al., 2009a; Okamoto et al., 2009), and upon induction of mito-
chondrial dysfunction (Nowikovsky et al., 2007; Priault et al.,
2005). Studies of mitophagy using yeast as a model organism
have strongly promoted our understanding of this complex
process in mammalian cells and its link to diverse pathologies.
To date, two well-established mechanisms have been described
for mitophagy in mammals. The first mechanism depends on
NIX, a selective autophagy receptor that is located at the outer
membrane of mitochondria and is required for mitophagy during
erythrocyte differentiation (Novak et al., 2010; Sandoval et al.,
2008). The second one plays a role in mitochondrial quality con-
trol by eliminating dysfunctional mitochondria and depends on
the mitochondrial kinase PINK1 and the E3 Ub ligase PARKIN,
two factors that are causally linked to Parkinson’s disease (Mat-
suda et al., 2010; Narendra et al., 2008; Vives-Bauza et al., 2010).
Although the role of ubiquitination in mitophagy in mammals is
well supported, up to now, there has been no evidence that ubiq-
uitination plays a role in regulating mitophagy in yeast cells.
In two previous studies, investigators performed large-scale
genomic screens for yeast mutants defective in mitophagy
induced by stationary-phase growth (Kanki et al., 2009a; Oka-
moto et al., 2009). To monitor mitophagy, they analyzed delivery
of a mitochondria-targeted fluorescent protein into the vacuole.
In each screen, 23 mutants that exhibited a specific mitophagy
defect without affecting other autophagy-related pathways
were identified. However, only a small overlap between the two
studies was found, which may be due to the different experi-
mental conditions employed. Results obtained from image-
based assays are commonly limited by the lack of quantitative
data, and consequently it has not been possible to reliably deter-
mine increased or partially inhibitedmitophagy by suchmethods.
Here, we report on the development of a powerful quantitative
genome-wide screening methodology to overcome these limita-
tions. Mitophagy was analyzed upon induction with rapamycin,
a condition that has never been investigated on a genome-wide
scale in yeast before. In principle, this method, which we term
synthetic quantitative array (SQA) technology, combines the
synthetic genetic array (SGA)-based generation of an enzymatic
tester mutant library with a subsequently performed quantitative
high-throughput assay. Using this technology, we discovered
numerous mitophagy- and autophagy-modulating factors, which
included both positive andnegative regulators of thesepathways.
Detailedanalysisof candidates revealedanunexpected roleof the
Ubp3-Bre5 deubiquitination complex in mitophagy regulation.
RESULTS
Strategy for the Genome-wide Identification of
Mitophagy Modulators by SQA Technology
To obtain genome-wide knowledge about the molecular fac-
tors that modulate mitophagy in yeast cells, we decided to
combine the strengths of the SGA methodology with a
biochemical high-throughput assay that would allow enzymatic
quantification of mitophagy (Figures 1A–1C). The quantitativeors
aspect of this SGA-based procedure led us to coin the term
‘‘synthetic quantitative array’’ (SQA) technology. In order to
analyze mitophagy in a precise and quantitative manner,
we used the previously described alkaline phosphatase
(ALP)-based assay for mitophagy (Mendl et al., 2011) with
some modifications. This assay relies on expression of an
inactive proenzyme of ALP targeted to the mitochondrial
matrix (mtALP). Upon mitophagy induction, a part of the
mtALP is delivered into the vacuole and activated by the
vacuolar proteinase A. For a genome-wide application of this
assay, we used the SGA methodology to cross a yeast
knockout collection of non-essential genes with 5,000 mutant
strains with a mitophagy tester strain lacking endogenous
PHO8 and harboring an mtALP expression vector (Figure 1A).
The resulting SQA mutant strains served as a mitophagy
tester library, which was subjected to a quantitative, high-
throughput screening procedure for rapamycin-induced mi-
tophagy. We applied a three-step ALP-based selection pro-
cedure (Figure 1A): (1) we miniaturized the ALP-based assay
technique and performed the first round of screening entirely
in 96-well plates in a high-throughput manner (genome-
wide screen), (2) we selected the top candidates and then
re-evaluated them in a second round of screening in 96-
well plates (confirmation screen), and (3) we validated the
remaining candidates by employing the well-established
ALP-based assay procedure, using flasks for cultivation (final
validation).
Generation of a Mitophagy Tester Mutant Library by a
Modified SGA Approach
To obtain the mitophagy tester mutant library, we used an
adapted SGA procedure (Figure 1B). The SGA technique
was originally developed for high-throughput genetic interac-
tion studies in S. cerevisiae and can be used for the system-
atic generation of haploid double-mutant arrays (Tong et al.,
2001). Here, we mated the MATa yeast knockout collection
of non-essential genes with a MATa mitophagy tester strain
that contained all of the genetic characteristics required
for the ALP-based assay procedure (Figure 1B). After selec-
tion for heterozygous diploid cells, the strains were sporu-
lated, leading to meiotic formation of haploid tetrads. The
mitophagy tester strain was additionally deleted for CAN1,
which encodes an arginine permease, conferring sensitivity
to the toxin canavanine. This locus was replaced by
STE2pr-his5 (S. pombe), a MATa-specific reporter. This dou-
ble selection strategy ensured efficient selection for MATa
haploid cells upon sporulation. Finally, we were able to
obtain an arranged array of haploid double mutants deleted
for PHO8 and a gene X of interest that contained the mtALP
plasmid. Among the original 4,922 deletion strains, 196
mutants failed to grow on YPD medium from the beginning,
which is not uncommon for large yeast libraries that have
been stored for long periods of time. Only 57 strains did
not survive the SGA procedure, possibly due to technical
limitations or synthetic lethal interactions. In summary,
this procedure allowed us to generate a library of 4,669
SQA mutant strains that could be quantitatively tested for
mitophagy.Cell RHigh-Throughput Quantification of the SQA Mutant
Library Revealed 324 Candidate Genes that Modulate
Mitophagy
To analyze mitophagy of all SQA mutants in a quantitative, high-
throughput manner, we had to miniaturize the standard ALP-
based assay protocol. We optimized the procedure so that
cultivation of SQA strains, induction of mitophagy, preparation
of cell extracts, and determination of ALP activity and protein
concentration could all be performed in 96-well plates (Fig-
ure 1C). Strains were grown on selective medium containing
glycerol as a non-fermentable carbon source. Mitophagy was
induced by addition of rapamycin and cells were harvested after
24 hr of incubation. We established a mechanical cell lysis
method using glass beads that allowed us to prepare total pro-
tein extracts from low amounts of cells. We then used these ex-
tracts to efficiently determine the specific mtALP activity of each
mutant. We analyzed the complete SQA library distributed on 53
plates by this screening procedure. The resulting specific
mtALP activity of each strain was normalized to the median of
all strains measured on the same plate to allow a better plate-
to-plate comparison. Arrangement of all SQA mutant strains ac-
cording to the obtained level of mitophagy (Figure 2A) shows
that, depending on the set thresholds, we were able to identify
a number of mitophagy-defective and -enhanced mutants. Us-
ing thresholds of <50.0% and >200.0% of normalized mitoph-
agy, we identified 295 deletion strains that exhibited a defect
in mitophagy (6.3% of all analyzed strains) and 29 deletion
strains that showed an increased mitophagy (0.6% of all
analyzed strains). Thus, we were able to perform a quantitative,
genome-wide analysis of mitophagy in yeast (Table S1), allow-
ing the reliable identification of both positive and negative reg-
ulators of this process.
A Two-Step Validation Procedure Identified 86 Genes
that Promote and 10 Genes that Inhibit Mitophagy
Next, we spotted the 324 identified potential mitophagy modula-
tors on new plates and subjected them to a second round of the
96-well-based screening procedure. The specific mtALP activity
of each strain was normalized to the averaged specific activity of
a positive control measured on the same plate. In order to mini-
mize falsely excluded mitophagy modulators, we set thresholds
(less stringently) to <60.0% and >150.0% of normalized mitoph-
agy. We further excluded ten mutants that have been annotated
by the manufacturer of the yeast deletion library (Open Bio-
systems) as being incorrect. We could confirm 230 mitophagy-
defective and 19 mitophagy-enhanced SQA mutant strains
(Table S2). We subsequently excluded one mutant deleted for
PEP4, encoding vacuolar proteinase A, or 17 already known
ATG genes. To finally validate our remaining candidates, we
quantified the rapamycin-induced mitophagy level of each
SQAmutant strain by the standard ALP-based assay procedure.
Using flasks for cultivation and a cell homogenizer for generation
of cell extracts, we were able to obtain quantitative data for each
strain in a robust and well-established manner. Furthermore, this
procedure allowed us to follow the growth behavior and to check
for mtALP expression and processing by western blot analysis.
We identified 197 strains with reduced rapamycin-induced mi-
tophagy levels and 12 strains with increased levels (Table S2).eports 10, 1215–1225, February 24, 2015 ª2015 The Authors 1217
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Figure 2. Identification of 86 Mitophagy-
Defective and 10 Mitophagy-Enhanced
Mutant Strains
(A) SQA strains were analyzed for rapamycin-
induced mitophagy in 96-well plates. The specific
mtALP activity of each strain was measured once
and normalized to the median specific activity of all
strains on the same plate. Strains were ranked ac-
cording to the extent of mitophagy induction.
Thresholds were set to <50.0% and >200.0% to
define mitophagy-defective and -enhanced mu-
tants, respectively. Normalizedmitophagy levels are
depicted on a logarithmic scale. See also Table S1.
(B) Schematic flow chart summarizing the results
of the SQA-based identification of modulators of
rapamycin-induced mitophagy. See also Figures
S2 and S3 and Tables S2 and S4.
(C) GO analysis of identified mitophagy modula-
tors compared with the entire yeast genome. See
also Table S5.We used thresholds of <75.0% and >150.0%, respectively,
compared with a positive control. Nine strains that did not
show mtALP expression were removed (Table S2). We also
excluded 93 strains that exhibited a growth defect under the
applied respiratory conditions, to minimize the probability that
our final list would contain mutants that are only indirectly
affected in mitophagy (Table S2). In 15 cases, the SQA strains
still expressed endogenous PHO8 (data not shown), presumably
due to a diploid contamination during mutant generation. To
analyze these genes, we regenerated the strains manually by
tetrad dissection and determined the levels of rapamycin-
induced mitophagy. Subsequently, 11 of these mutants (four
based on the set thresholds and seven based on their growth
behavior) could be excluded from the final list of mitophagymod-
ulators (Table S2).1218 Cell Reports 10, 1215–1225, February 24, 2015 ª2015 The AuthorsAfter performing three steps of
screening and validation, and applying
various conservative selection criteria,
we identified a total of 96 mitophagy
modulators, 86 of which promotemitoph-
agy and 10 of which inhibit mitophagy
(Figure 2B; Tables S1 and S2). During
the final validation, we also compared
some of the identified candidate mutants
with well-established positive and nega-
tive controls, including strains lacking
atg32, atg11, and atg1, which were
excluded from our list of final candidates
(Figure S3). Notably, a total of 100
additional deletion mutant strains, which
exhibited strongly reduced cell growth
under the applied respiratory conditions,
were found to be impaired in mitophagy
(Tables S2 and S4).
Next, in order to classify the 96 mitoph-
agy modulators, we performed a Gene
Ontology (GO) analysis by using annota-
tion data for specific GO terms provided by the Gene Ontology
Consortium (Ashburner et al., 2000) (Figure 2C; Table S5). Most
of the gene products (70%) were reported to show a cytoplasmic
localization, which is statistically expected considering the distri-
bution of annotation data for the entire yeast genome (63%). Yet,
we noted a high proportion of mitophagy modulators being local-
ized to mitochondria (29%). This seems to be clearly overrepre-
sented compared with the yeast genome (18%), indicating that
certain steps ofmitophagy are spatially controlled at the organelle
(Figure 2C). Also, vacuolar proteins appear to be relatively en-
riched in our data set. The fact that the absolute number of such
genes is rather low can be attributed to our exclusion of ATG
genes (Table S3, bottom part), some of which represent essential
vacuole-associated proteins. Next, we analyzed the biological
processes in which the potential mitophagy modulators are
Figure 3. Classification of Modulators of Rapamycin-Induced
Mitophagy
Levels of rapamycin-induced mitophagy and non-selective autophagy of 96
mitophagy-affected mutants were used to classify them into six categories.
Arrows indicate a decrease (red) or an increase (blue) of the respective process
in the corresponding deletion strains. See also Table S3.involved. For most of the identified gene products, the respective
biological pathway is unknown (21%),which is consistentwith the
distribution of annotations for the yeast genome. However, we
observed that mitophagy modulators showed a clear preference
for being involved in mitochondrial functions (organization, trans-
lation, and metabolism), consistent with enrichment of mitochon-
dria-localized candidates. In addition, other processes, such as
stress response pathways, protein modifications by Ub or other
small proteins, and protein targeting, are overrepresented among
the mitophagy modulators.
Identification of 63 Specific Mitophagy Modulators by
SQA-Based Autophagy Analysis
In order to determine which of the identified mutants are specif-
ically affected in mitophagy, we in addition analyzed the level of
non-selective autophagy induced by rapamycin in these strains.
For this purpose, we employed the ALP-based assay for general
autophagy using a cytosol-targeted proenzyme of ALP (cytALP)
(Mendl et al., 2011). To determine autophagy within the 96 mi-
tophagy-modulating mutants, we applied the SQA technology
once more by crossing the respective single gene deletion
strains with an autophagy tester strain that met the genetic re-
quirements for the cytALP-based assay. We quantified the level
of rapamycin-induced non-selective autophagy for each strain
using the standard ALP-based assay procedure (Table S3). ByCell Rcomparing the levels of rapamycin-induced mitophagy and
autophagy for all of the analyzed mutant strains, we were able
to classify the strains into six categories (Figure 3; Table S3).
Most of the strains (55) were specifically defective in mitophagy,
as general autophagy was largely unaffected. Two strains
(Dbud27 and Dygr160w) were specifically enhanced in mitoph-
agy without showing an effect on autophagy induction. Impor-
tantly, we also identified six strains in which both processes
were inversely regulated: three mutants (Dhap3, Dssn3, and
Dynl170w) were specifically defective for mitophagy and
enhanced in autophagy, whereas the other three mutants
(Dbre5, Dubp3, and Ddss1) were affected in the opposite
manner. This strongly argues for the existence of regulatory
pathways that canmodulate selectivemitophagy and non-selec-
tive autophagy in a reciprocal manner. Twenty-eight deletion
mutants exhibited defects in the induction of rapamycin-induced
mitophagy as well as autophagy, whereas five deletion mutants
showed a strong increase in both levels. Thus, we conclude that
the SQA technology as applied here also identified a total of 33
genes that modulate autophagy in a general manner. As those
genes do not affect mitophagy specifically, we excluded them
from our final candidate list. In summary, we identified 63 spe-
cific modulators for rapamycin-induced mitophagy in yeast (Fig-
ure 3; Table S3).
Ubp3 and Bre5 Regulate Mitophagy and Autophagy in a
Reciprocal Manner
Next, we focused on two of the three mutant strains that on the
one hand showed enhanced mitophagy but on the other hand
reduced non-selective autophagy upon rapamycin treatment,
namely, Dupb3 and Dbre5. We did this for three reasons: First,
the factors Ubp3 and Bre5 were previously reported to be part
of the sameprotein complex (Li et al., 2005). Second, both factors
are required for the deubiquitinating activity of this complex
(Cohen et al., 2003), indicating that ubiquitination might play a
role during mitophagy in S. cerevisiae. Third, such a reciprocal
behavior has not been observed before, pointing to an interde-
pendent means of regulating distinct autophagic processes. To
corroborate the results from the SQA-based experiments, we
manually crossed the corresponding single gene deletion strains,
Dubp3 and Dbre5, with a Dpho8 mutant by performing tetrad
dissection. After transformation with the respective ALP expres-
sion plasmids, we quantified the rapamycin-induced levels for
mitophagy and autophagy using the standard ALP-based assay
procedure. Indeed, the mitophagy levels were elevated in both
mutants to 160%, whereas autophagy levels were decreased
to 40% compared with the wild-type level, confirming our
SQA-based results (Figures 4A and 4B, top). The extent of ALP
processing as revealed by western blot analysis was consistent
with these results (Figures 4A and 4B, bottom). Expression of
Ubp3 and Bre5 under control of the endogenous promotor effi-
ciently reversed the effects observed for the corresponding dele-
tion strains (Figures 4C–4F), revealing the specificity of the mi-
tophagy enhancement and autophagy reduction in bothmutants.
We next tested the effect of the Ubp3-Bre5 deubiquitination
complex on mitophagy and autophagy under different induction
conditions. After shifting the cells from lactate-containing me-
dium to glucose-containing medium lacking nitrogen (nitrogeneports 10, 1215–1225, February 24, 2015 ª2015 The Authors 1219
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Figure 4. UBP3 and BRE5 Affect Mitophagy
and Non-selective Autophagy in a Recip-
rocal Manner
(A and B) Strains deleted for the indicated genes
and for endogenous PHO8 expressing mtALP (A)
or cytALP (B) were analyzed by the standard
ALP-based assay (top). Cells were grown in SG
medium and treatedwith rapamycin for 24 hr or left
untreated. Specific ALP activities are given as
means ± SD (nR 3) normalized to the rapamycin-
treated wild-type control. Proteolytic processing
of mtALP (A) or cytALP (B) was determined by
western blot analysis of total cell extracts (bottom).
Bmh2 served as the loading control.
(C–F) Strains deleted for the indicated genes
and for endogenous PHO8 expressing mtALP
(C and E) or cytALP (D and F) and endogenously
expressing Ubp3 (C and D), Bre5 (E and F), or
empty vector were analyzed as described above.
Mean ± SD of at least three independent experi-
ments normalized to control is shown. Signifi-
cance levels p< 0.05 (*) or p<0.01 (**) using a
Student’s t test are indicated. See also Figure S1.starvation), we found that autophagy induction was extensively
impaired in both the Dubp3 and Dbre5 strains, whereas mitoph-
agy was not significantly altered even after 24 hr of starvation
(Figure S1A). Although mitophagy was not increased in both mu-
tants, it was still clearly regulated differently compared with non-
selective autophagy under these conditions. Cultivating Dubp31220 Cell Reports 10, 1215–1225, February 24, 2015 ª2015 The Authorsand Dbre5 strains in a medium containing
a non-fermentable carbon source (glyc-
erol or lactate) to the stationary phase
resulted in a significantly higher induction
of mitophagy and lower induction of
autophagy when compared with the
wild-type control after 24 hr of growth
(Figure S1B). This is fully in line with
the data we obtained using rapamycin
for mitophagy induction. In summary,
we conclude that Ubp3/Bre5-dependent
deubiquitination inhibits mitophagy and
at the same time promotes non-selective
autophagy. Thus, both processes appear
to be regulated in an opposing manner.
Ubp3 and Bre5 Translocate
Dynamically from the Cytosol to
Mitochondria when Mitophagy Is
Induced by Rapamycin
In mammals, it is well established that
PARKIN, an E3 Ub ligase, translocates
to mitochondria upon induction of mi-
tophagy (Narendra et al., 2008; Vives-
Bauza et al., 2010). Here, we sought to
determine where Ubp3 and Bre5 are
located in the cell, and whether their
subcellular localization is altered when
mitophagy is induced. We used strainsexpressing C-terminal GFP fusion proteins of Ubp3 and Bre5:
Ubp3-GFP and Bre5-GFP. These strains were treated with
rapamycin for 1, 5, or 24 hr, or remained untreated as a control.
Under normal growth conditions, both fusion proteins showed a
dual localization, namely, cytosolic and mitochondrial (Figures
5A and 5B, control images). After induction of mitophagy with
Figure 5. Ubp3 and Bre5 Translocate
Dynamically from the Cytosol to Mito-
chondria upon Induction of Mitophagy
(A–D) Strains expressing mitoDsRED and either
C-terminal GFP fusion proteins of Ubp3 (A and
C) or Bre5 (B and D) were analyzed by fluo-
rescence microscopy (A and B) or western blot
(C and D).
(A and B) Strains were treated with rapamycin for
1, 5, or 24 hr, or were left untreated as a control.
More than 50 cells were counted in three inde-
pendent experiments and the percentage of cells
with GFP signal in the mitochondria (Mito) only
or mitochondria and cytosol (Mito + Cytos.) was
determined (right in A and B). Representative
images are shown on the left.
(C and D) Mitochondria were isolated after 0 or
24 hr treatment with rapamycin and the subcel-
lular localization of Ubp3-GFP (C) and Bre5-GFP
(D) was determined by western blot analysis
using an anti-GFP antibody. Tim44 served as the
loading control.rapamycin, both proteins dynamically translocated from the
cytosol to mitochondria (Figures 5A and 5B). At 24 hr, both pro-
teins showed a nearly exclusive mitochondrial localization and
the GFP signal in the cytosol disappeared in most cells. This dy-
namic translocation became detectable after 5 hr, but not after
1 hr, suggesting a short time lag. It further appears that Bre5 re-
locates faster thanUbp3, since after 5 hr, Bre5was almost exclu-
sively located at mitochondria. For both strains, a weak GFP
signal in the vacuole became evident with increasing times of ra-
pamycin treatment, which can be attributed to the general induc-
tion of autophagy and mitophagy. We further corroborated the
relocation of both proteins to mitochondria by western blot anal-
ysis (Figures 5C and 5D). Based on these results, we conclude
that both core subunits of the Ubp3-Bre5 deubiquitinase com-
plex dynamically relocate from the cytosol to mitochondria
upon rapamycin treatment, suggesting a direct role in regulation
of mitophagy.Cell Reports 10, 1215–1225, FMitophagy Is Regulated Differently
from Other Selective Types of
Autophagy by the Ubp3-Bre5
Deubiquitination Complex
To address how other types of selective
autophagy are affected in Dubp3 and
Dbre5 mutants, we first analyzed the
selective degradation of ribosomes,
termed ribophagy, which was previously
reported to be reduced in these strains
during starvation (Kraft et al., 2008).
For this purpose, we applied the previ-
ously described Rpl25-GFP-processing
assay (Kraft et al., 2008) in wild-type,
Dubp3, Dbre5, and Datg1 cells that
were cultivated under respiratory
conditions and treated or not treated
with rapamycin (Figure 6A). Free GFP
clearly accumulated in wild-type cellscompared with the untreated control. Rpl25-GFP degradation
was completely blocked in the Datg1 mutant, which is
defective in all autophagy-related pathways and served as a
negative control. In Dubp3 and Dbre5 cells, processing of
Rpl25-GFP was moderately reduced upon rapamycin treat-
ment when compared with the wild-type, consistent with the
results of Kraft et al. (2008).
Next, we analyzed whether the Cvt pathway is affected in
Dubp3 and Dbre5 strains. We examined Ape1 processing
in wild-type,Dubp3,Dbre5, andDatg1 cells under the same con-
ditions as described above (Figure 6B). The precursor form
pr-Ape1 was clearly processed, generating the mature form
m-Ape1 in untreated wild-type cells. Processing was drastically
increased after treatment with rapamycin. In contrast, it was
completely blocked in Datg1 cells under both conditions, indi-
cating a complete block of the Cvt pathway. Bothmutant strains,
Dubp3 and Dbre5, exhibited a moderate reduction in Ape1ebruary 24, 2015 ª2015 The Authors 1221
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Figure 6. Other Types of Selective Autophagy Are Impaired inDubp3
and Dbre5 Cells
(A) Analysis of rapamycin-induced ribophagy. The indicated strains expressing
Rpl25-GFP were grown in SG medium and treated with rapamycin for 24 hr or
left untreated. Vacuolar cleavage of Rpl25-GFP and generation of free GFP
was determined by western blot analysis of total cell extracts.
(B) Analysis of the Cvt pathway. Strains deleted for the indicated genes were
analyzed as in (A). Proteolytic processing of Ape1 was determined by western
blot analysis of total cell extracts. Bmh2 served as the loading control.processing in untreated cells as well as after rapamycin treat-
ment compared with the wild-type.
In summary, mitophagy is apparently the only autophagy-
related pathway that is upregulated under the applied conditions
when components of the Ubp3-Bre5 complex are absent. Non-
selective autophagy as well as two selective types of autophagy,
ribophagy and the Cvt pathway, were impaired. These findings
strongly point to a unique and specific regulation of mitophagy
by the Ubp3-Bre5 deubiquitination complex.DISCUSSION
Obtaining quantitative biochemical data from gene deletion li-
braries on a genome-wide scale is highly valuable for identifying
molecular factors involved in complex biological processes.
Moreover, such data form the basis for generating theoretical
models in systems biology. Here, we developed a technique,
termed SQA technology, that allowed us to identify a number
of previously unknown modulators of mitophagy in yeast and
can be easily applied to other enzyme-based reporter assays
(Figure 1A). The first step exploits the power of the well-estab-
lished SGA technique and is required to generate amutant tester
library that harbors the gene deletions of interest and meets the
genetic requirements for the respective enzyme-based reporter
system. The next step is to obtain quantitative data from this
tester library in a high-throughput manner. For this purpose,
we had to develop a large-scale protocol that would allow us
to collect total protein extracts from several thousands of yeast
strains after applying a standardized protocol for mitophagy in-1222 Cell Reports 10, 1215–1225, February 24, 2015 ª2015 The Authduction. In this study, wewere able to demonstrate the suitability
of this technique for the quantitative analysis of mitophagy as
well as non-selective autophagy in yeast.
One general advantage of the SQA technology compared with
currently used cell- or colony-based reporter assays using fluo-
rescent proteins or colorimetric staining techniques is that even
weakmodulators can be identified and ranked based on detailed
quantitative data. Moreover, evenmoderate increases in enzyme
activity can be monitored, which is difficult to do with image-
based approaches and allows for identification of negative reg-
ulators of mitophagy.
Highly reproducible data were obtained, as >75% of all candi-
dates identified in the initial genome-wide screen were corrobo-
rated in the second confirmation round. More than 90% of the
remaining candidates were verified using the standard ALP-
based assay, demonstrating the robustness of the method even
when performed on a 96-well scale (Figure 2B). Deletions of 27
ATG genes have been associated with defects in mitophagy
(Kanki et al., 2011). Notably, 25 of the respective deletionmutants
are included inourgeneratedSQA library (TableS1).Using thresh-
olds of <50.0% and <75.0% in the first genome-wide screening
round led to the identification of 16 (64%) and 23 (92%) of
these mutants, respectively. When ATG mutants reported to be
only partially defective in mitophagy (ATG21, ATG23, ATG27,
ATG29, ATG31, and ATG33) are excluded from this reference
set, 19 severely affected mutant strains remain. Of these strains
15 (79%) or 17 (89%) could be confirmed using thresholds
of <50.0% or <75.0%, respectively. We therefore conclude that
our genome-wide screen has a high sensitivity of 80%–90%.
Our general goal in developing the SQA-based screen was
to obtain a detailed mechanistic insight into the regulation of
mitophagy in baker’s yeast. This is highly relevant because
impaired removal of dysfunctional mitochondria by mitophagy
has been implicated in the pathogenesis of numerous diseases
in humans, such as Parkinson’s disease (Narendra et al., 2008;
Youle and Narendra, 2011). Although some genomic screens
for mitophagy have been performed in higher and lower eukary-
otes (Kanki et al., 2009a; Lefebvre et al., 2013; Okamoto et al.,
2009; Orvedahl et al., 2011), our approach is unique because it
is quantitative and uses a specific TOR kinase inhibitor, rapamy-
cin, as the inductor of mitophagy. In summary, using stringent
criteria, we identified 86 mitophagy-defective and 10 mitoph-
agy-enhancedmutant strains, which therefore represent positive
and negative modulators of mitophagy, respectively (Figure 2A).
We also identified 100 other deletion mutants that were
strongly affected in mitophagy and in addition showed a severe
respiratory growth defect (Table S4). We excluded these mu-
tants from our final list of candidates, as during ALP-based anal-
ysis, strains that are found to be impaired in respiratory growth
often tend to exhibit a reduction in both mitophagy and non-
selective autophagy, which is likely to have resulted from sec-
ondary effects. However, we should emphasize that it is possible
that specific regulators of mitophagy are represented within this
group of candidates. This is actually supported by the fact that
not all strains that were previously reported to be respiratory
deficient exhibited a reducedmitophagy response. Furthermore,
a recent screen of respiratory-deficient mutant strains identified
several candidate genes for mitophagy modulators (Bo¨cklerors
and Westermann, 2014). That study also provided evidence that
respiratory deficiency does not impair mitophagy per se.
By applying the SQA technology to determine rapamycin-
induced, non-selective autophagy, we were able to define six
categories of mutant strains giving rise to 33 general autophagy
modulators and 63 specific mitophagy modulators (Figure 3).
Although many of these strains have not been linked to these
processes before, we could confirm ATG32, EGD1, WHI2,
MDM31, and HAP3 as mitophagy modulators, consistent with
earlier reports (Bo¨ckler and Westermann, 2014; Kanki et al.,
2009b; Mendl et al., 2011; Okamoto et al., 2009). It is remarkable
that about two-thirds of all identified modulators seem to be
specifically required for mitophagy. In our view, this further dem-
onstrates how little we know about the regulation of mitophagy,
in particular when induced by rapamycin.
Regarding the final list of 63 specific mitophagy modulators,
we noted that only two genes (ATG32 and EGD1) were
commonly identified in the three genome-wide mitophagy
screens that have been performed in S. cerevisiae to date (Fig-
ure S2). This is most likely due to the different experimental con-
ditions applied for induction of mitophagy. Apparently, selective
degradation of mitochondria is a complex process that is differ-
entially regulated depending on specific mitophagy-inducing
signals. Furthermore, all of these studies differed in the method
used to monitor mitophagy, emphasizing the necessity to
retrieve detailed quantitative data from large-scale experiments.
However, at least ATG32 and EGD1 seem to regulate mitophagy
independently of the inductionmode, pointing to a universal core
machinery that apparently is modulated by various upstream
factors depending on the environmental conditions applied.
Obtaining distinct quantitative data for mitophagy and auto-
phagy by using SQA technology allowed us to get a handle on
regulatory mechanisms that affect both processes differentially.
Notably, this depends on reliable detection of increased levels of
mitophagy and autophagy, which has not been systematically
addressed before. Earlier fluorescence-based screens were
clearly designed to identify mutant strains with defective mitoph-
agy (Kanki et al., 2009a; Okamoto et al., 2009). In our study, a
small subset of ten mutant strains showed an increase in
rapamycin-induced mitophagy (Figure 3). Five of them (Dleu3,
Dpmr1, Dvps1, Dnsr1, and Drmr1) affected non-selective auto-
phagy in a similar manner and thus appear to be general inhibi-
tors of rapamycin-induced autophagy in yeast. The five remain-
ingmitophagy-enhanced deletion strains exhibited no significant
effect on autophagy (Dbud27 and Dygr160w) or were inversely
affected (Dbre5,Dubp3, andDdss1). These genes encode nega-
tive regulators of mitophagy, representing a class of mitophagy
modulators that have not been characterized to date.
We focused on two factors, Ubp3 and Bre5, because they
both showed the same reciprocal response regardingmitophagy
and autophagy (Figure 4) and were reported to exist in a single
protein complex (Li et al., 2005). Ubp3 is one of 16 known Ub-
specific proteases in yeast that cleave Ub from Ub-conjugated
proteins. Ubp3 activity requires the positive regulator Bre5 as a
cofactor (Cohen et al., 2003). This complex has been reported
to play a regulatory role in diverse cellular pathways, including
anterograde and retrograde transport, the Ras/PKA signaling
pathway, transcriptional activation, and protein quality controlCell R(Brew and Huffaker, 2002; Cohen et al., 2003; Li and Wang,
2013; Sole´ et al., 2011). The Ubp3-Bre5 complex is also required
for starvation-induced ribophagy via deubiquitination of ribo-
somal proteins in the cytoplasm (Kraft et al., 2008), which is
corroborated by our study (Figure 6A). Furthermore, this com-
plex was associated with regulation of the Cvt pathway by
modulating the ubiquitination status of Atg19 (Baxter et al.,
2005). Our finding that both Ubp3 and Bre5 inhibit mitophagy
and at the same time promote bulk autophagy, ribophagy, and
the Cvt pathway (Figures 4, 5, and 6) has several important impli-
cations. First, regulation of rapamycin-induced mitophagy in
yeast depends on the ubiquitination/deubiquitinationmachinery.
This mode of regulating mitophagy is already well established in
mammals, but to date has not been described in baker’s yeast. It
indicates the existence of conserved Ub-dependent regulatory
mechanisms of mitophagy in eukaryotes, supporting the view
that baker’s yeast is a useful model organism for mitophagy
research. Ubiquitination of mitochondria could be a signal for
their degradation, and therefore deleting components of the
Ubp3-Bre5 deubiquitination machinery would result in increased
mitophagy rates. It further suggests that rapamycin-induced
mitophagy in yeast andmitophagy of dysfunctional mitochondria
in mammals at least share ubiquitination as a common regula-
tory mechanism. Second, it strongly displays a reciprocal and
interdependent regulation of different autophagy pathways. In
contrast to its effect on mitophagy, deubiquitination seems to
be essential for the progression of non-selective autophagy
(Figure 4B). Interestingly, a potential role of Ub in non-selective
autophagy pathways has not yet been described in yeast and
mammals. Even different types of selective autophagy seem to
be differentially regulated by the Ubp3-Bre5 complex (Figure 6).
This implies that mitophagy and other types of autophagy,
including ribophagy, are mechanistically linked but appear to
represent competing processes. What could be the physiolog-
ical advantage of such a reciprocal regulation? In the case of
degradation of cytoplasmic ribosomes, one could imagine that
under conditions of increased stress during translation, e.g., by
stalled ribosomes or protein aggregation of nascent polypep-
tides, it is a high priority to restore functional protein synthesis,
which can be promoted by ribophagy of non-functional
ribosomes. Simultaneous induction of mitophagy could limit
components of the autophagymachinery required for ribophagy.
Moreover, when cytoplasmic protein translation is inhibited,
mitochondrial biogenesis (which largely relies on cytosolic pro-
tein synthesis and import into mitochondria) becomes impaired.
This may result in the accumulation of temporarily dysfunctional
mitochondria due to a lack of import of newly synthesized
components. In order to prevent unwanted and excessive
degradation of those temporarily impaired organelles, it is well
conceivable that limiting mitophagy at the same time would be
beneficial. Conversely, under conditions in which primarily mito-
chondria are dysfunctional, it would be beneficial to promote
mitophagy and repress other types of autophagy. This would
ensure that components of the general autophagy machinery
would not be limiting. Based on our results, we propose that
such a reciprocal regulatory switch could ensure that, depending
on the kind of stress inflicted, the type of autophagy pathway that
copes best with this stress is specifically enhanced, albeit at theeports 10, 1215–1225, February 24, 2015 ª2015 The Authors 1223
expense of other types of autophagy. For mitophagy, we sug-
gest that Ubp3-Bre5 is a critical part of this regulatory switch.
Moreover, the observed dynamic relocation of Ubp3-Bre5 from
the cytosol to mitochondria (Figure 5) could mechanistically
explain this reciprocal behavior. In this scenario, for example,
Ubp3-Bre5 would be less available for ribophagy in the cytosol
and at the same time would inhibit mitophagy by deubiquitinat-
ing mitochondrial proteins at the outer membrane.
In summary, we have developed a quantitative technology that
can be applied to a wide range of biological problems. Using this
technology, we were able to identify a large collection of factors
that modulate mitophagy in both positive and negative ways.
Finally, we discovered that the Ubp3-Bre5 deubiquitination com-
plex is involved in reciprocal regulation of mitophagy in relation
to other types of autophagy. An important implication of this is
that our concept of how autophagic processes affect each other
has to be revised. The molecular details of how these regulatory
switches work and how mitochondrial quality control is linked to
other cellular stress response pathways are still unclear. Still, we
believe that large-scale genetic studies can form the basis to
address these challenging issues.
EXPERIMENTAL PROCEDURES
Yeast Strains, Plasmids, and Growth Conditions
Yeast strains, plasmids, oligonucleotides, experimental details for plasmid
construction, and growth conditions are provided in the Supplemental
Experimental Procedures.
Generation of a Mitophagy Tester Mutant Library
We adapted the SGA procedure described previously (Tong et al., 2001) as fol-
lows: Tester strain design included deletion of PHO8 by a natMX cassette and
deletion ofCAN1 replaced by the STE2pr-his5 (S. pombe) reporter. ThemtALP
and cytALP plasmids were introduced for the mitophagy- and autophagy-
based SQA approach, respectively. Tester strains are listed in Table S4. Single
gene deletion strains from the MATa (BY4742; his3D1; leu2D0; lys2D0;
ura3D0) yeast knockout collection obtained from Open Biosystems (GE
Healthcare) were crossed with the respective tester strain (MATa), and several
pinning steps on different selective media gave rise to an arranged array of
haploid double mutants that could be analyzed with the ALP-based assay (Fig-
ure 1B). It should be noted that a few of the strains in the original deletion library
are known to be incorrect and that we did not confirm the deletion for all candi-
date genes. However, we confirmed proper gene deletion for at least some
mutant strains, including Dubp3 and Dbre5. The media used for the SGA
procedure are listed in the Supplemental Experimental Procedures. After cells
were mated on YPD medium at 30C for 1 day, strains were selected for het-
erozygous diploids on SED-Leu + G418/clonNat medium at 30C for at least
2 days. Diploid cells were then subjected to sporulation on KOAc medium
and incubated at 22C for 7 days. Next the spore-containing cell material
was selected forMATa haploid cells on SCD-Leu/His/Arg + canavanine/3-ami-
notriazolemedium at 30C for 4 days. The latter procedure was repeated once.
To finally isolate specific haploid double-deletion mutants, cells were first sub-
jected to SED-Leu/His/Arg + canavanine/G418/3-aminotriazole medium at
30C for at least 3 days, and then for a final selection were spotted on SED-
Leu/His/Arg + canavanine/G418/clonNat/3-aminotriazole medium at 30C
for at least 3 days. Strains were analyzed for growth defects and stored in
20% glycerol-containing medium in 96-well plates at 80C.
High-Throughput Screening Method
SQA strains were grown in sterile 96-well plates under respiratory conditions.
Plates were cultivated at 30C with shaking at 200 rpm. Humidity was
conferred by wet tissues. The strains were inoculated in 200 ml SG-Leu me-
dium and subsequently diluted several times with fresh medium to maintain1224 Cell Reports 10, 1215–1225, February 24, 2015 ª2015 The Authexponential growth (Figure 1C). Before each dilution step, mutant strains
were resuspended and optical density (OD600nm) was measured. Mitophagy
was induced by addition of 1 mM rapamycin and cells were harvested after
24 hr of incubation. Before harvesting, OD600nm was measured and plates
were centrifuged at 4,000 3 g for 15 min. Pellets were washed with 100 ml
ice-cold 2 mM phenylmethanesulfonyl fluoride (PMSF), frozen in liquid nitro-
gen, and stored at 80C. For preparation of total cell extracts, pellets were
resuspended in 100 ml ice-cold lysis buffer (10 mM MgCl2, 0.1 M KOAc,
50 mM KCl, 10 mM ZnSO4, 20 mM PIPES [pH 7.0], 0.5% Triton X-100, 1 mM
PMSF). After addition of 150 mg glass beads (B 0.5 mm; Carl Roth), the
plates were sealed with a plastic film and shaken using a vortex mixer (VXR
basic Vibrax; IKA) at 2,000 rpm for 4 min. After addition of 50 ml lysis buffer,
the cell lysates were centrifuged at 4,000 3 g for 10 min at 4C. The superna-
tant was transferred to a new plate and stored at 20C. ALP activity was
determined by incubating 20 ml of the cell lysate with 105 ml of reaction buffer
(40 mMMgCl2, 0.5% Triton X-100, 0.25 M Tris-HCl [pH 8.5], 4 mM p-nitrophe-
nylphosphate) at 37C for 15 min. The reaction was stopped by adding 125 ml
2 M glycine-NaOH (pH 11.0), and absorption was determined at 405 nm. Pro-
tein concentration was determined by using the BCA Protein Assay (Thermo
Fisher) according to the manufacturer’s instructions and used to calculate
the specific ALP activity for each cell lysate. The specific ALP activities were
then normalized to the median of all strains on the same plate (genome-wide
screen) or to the averaged specific activity of four positive control strains
(confirmation screen) measured on the same plate.
ALP Assay for Mitophagy and Autophagy
For quantification of mitophagy and autophagy levels, individual yeast strains
deleted for PHO8 and containing mtALP- or cytALP-expressing plasmids,
respectively, were analyzed as described previously (Mendl et al., 2011).
Specific activities were normalized to the specific activity of a control strain.
Cell lysates were subjected to SDS-PAGE and western blotting.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and five tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.01.044.
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